NADD 2016 DSM 5 diagnostic criteria for bipolar and related disorders in persons with ID Acknowledgement Coauthors Lauren Charlot Sherman Fox Jessica Hellings Anne D Hurley Disclosures ID: 579496
Download Presentation The PPT/PDF document "Robert J. Pary" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
Robert J. ParyNADD 2016
DSM 5 diagnostic criteria for bipolar and related disorders in persons with
IDSlide2
Acknowledgement
Co-authors
Lauren
Charlot
Sherman Fox
Jessica
Hellings
Anne D. HurleySlide3
Disclosures
NoneSlide4
Aim
To update evidence-based literature pertaining to the diagnosis of bipolar and related disorders in persons
with IDSlide5
Historical context
It is only in the past
three plus decades
that clinicians generally accepted the notion that a person with ID might be able to experience a mood disorder such as a bipolar
disorder
Slide6
Current Goal
E
nsure
reliable assessments at the symptom level rather than developing new sets of
criteria
Use clear
behaviorally based descriptions of possible manifestations of each
DSM-5
symptom
criterionSlide7
Work Group
In the DSM-IV-TR (and
in
DM-ID),
Bipolar
Disorders were included in the
Mood
Disorders
chapter
In DSM5 and DM-ID2, Bipolar and Related Disorders comprise a separate chapterSlide8
Potential Bias
To varying degrees, members of the work group believed that during the past several years the diagnosis (and subsequent pharmacologic treatment) of bipolar
disorders
spiked in persons with IDDSlide9
DSM5 CRITERIA Manic EpisodeCriterion A
A
distinct period
of abnormally and
persistently
elevated, expansive,
or
irritable
mood
AND
Slide10
DSM5 CRITERIA Manic EpisodeCriterion A
abnormally
and
persistently
increased
goal-directed activity or
energy Slide11
DSM5 CRITERIA Manic EpisodeCriterion A
lasting at least 1 week
and present
most
of the day,
nearly every day
(or
any
duration if
hospitalization
is necessary
)Slide12
DSM5 CRITERIA Manic EpisodeCriterion B
During the period of mood disturbance
and
increased energy or activity Slide13
DSM5 CRITERIA Manic EpisodeCriterion B
three (or more) of the following symptoms (four if the mood is
only
irritable) are present to a significant
degree AND Slide14
DSM5 CRITERIA Manic EpisodeCriterion B
represent a noticeable change from usual
behavior
:Slide15
DSM5 CRITERIA Manic EpisodeCriterion B
1. Inflated self-esteem or grandiositySlide16
DSM5 CRITERIA Manic EpisodeCriterion B
2. Decreased need for sleep (e.g., feels rested after only 3 hours of sleep)Slide17
DSM5 CRITERIA Manic EpisodeCriterion B
3. More talkative than usual or pressure to keep talkingSlide18
DSM5 CRITERIA Manic EpisodeCriterion B
4. Flight of ideas or subjective experience that thoughts are racingSlide19
DSM5 CRITERIA Manic EpisodeCriterion B
5. Distractibility (i.e., attention too easily drawn to unimportant or irrelevant external stimuli)Slide20
DSM5 CRITERIA Manic EpisodeCriterion B
6. Increase in goal-directed activity (either socially, at work or school, or sexually) or psychomotor agitationSlide21
DSM5 CRITERIA Manic EpisodeCriterion B
7. Excessive involvement in pleasurable activities that have a high potential for painful consequences (e.g., engaging in unrestrained buying sprees, sexual
indiscretions etc.)Slide22
DSM5 CRITERIA Manic EpisodeCriterion C
The mood disturbance is sufficiently severe to cause marked impairment in social or occupational functioning
ORSlide23
DSM5 CRITERIA Manic EpisodeCriterion C
to necessitate hospitalization to prevent harm to self or others
ORSlide24
DSM5 CRITERIA Manic EpisodeCriterion C
there are psychotic
featuresSlide25
DSM5 CRITERIA Manic EpisodeCriterion D
The episode is not attributable to the physiological effects of a substance (e.g., a drug of abuse, a medication, other treatment)
ORSlide26
DSM5 CRITERIA Manic EpisodeCriterion D
a general medical condition (e.g., hyperthyroidism
)Slide27
DSM5 CRITERIA Manic EpisodeCriterion
Note:
A full manic episode that emerges during antidepressant treatment (e.g., medication, electroconvulsive therapy)
but persists at a fully
syndromal
level
beyond
the physiological effect of that
treatmentSlide28
DSM5 CRITERIA Manic EpisodeCriterion
is sufficient evidence for a manic episode and, therefore, a bipolar I
diagnosisSlide29
DSM5 Categories
Bipolar I Disorder
Bipolar II Disorder
Cyclothymic Disorder
Substance/Medication-Induced Bipolar and Related Disorder
Induced Bipolar and Related
Disorder Due to Another Medical Condition
Other Specified Bipolar and Related Disorder Unspecified Bipolar and Related DisorderSlide30
Diagnostic Issues between General Population and Persons with ID
Rapid cycling,
4
or more episodes in a year,
is
more
common
in persons with ID than in
general population
Cerebral dysfunction is presumed to be a factor in the increased risk of rapid
cyclingSlide31
Diagnostic Issues between General Population and Persons with ID
Developmental
stage
can affect
cognitive
symptoms of mania (i.e.
"
inflated self-esteem or grandiosity"
)Slide32
Diagnostic Issues between General Population and Persons with ID
When cognitive symptoms are described in people with ID, content may be
simplified
M
ay believe
they possess more normal abilities
they
actually
have
Arrange for wedding but no girlfriend
Try to buy a car but no driver’s license Slide33
Diagnostic Issues between General Population and Persons with ID
Pressured speech can appear as increased vocalization (rate or volume) or gesturing in individuals who have limited expressive language Slide34
Diagnostic Issues between General Population and Persons with ID
M
ight
be completely silent during depressive episodes but
vocalizes
or babbles almost continuously during manic
periods
Slide35
Diagnostic Issues between General Population and Persons with ID
Distractibility may manifest as changes in ability
level
N
o
longer completing daily living activities
S
kipping
from one activity to
another Slide36
Diagnostic Issues between General Population and Persons with ID
I
ncreased
energy
W
alking
for miles
Repeatedly
changing
clothes
M
ore
frenzied
baseline behaviors
R
apidly
piling up books or aligning
objectsSlide37
Diagnostic Issues between General Population and Persons with ID
Occasionally, one behavior can capture several manic
criteria
V
igorous
masturbation
LASTING throughout
the night
K
nocked mattress
off
bed Slide38
Diagnostic Issues between General Population and Persons with ID
R
ecording
of challenging
behaviors can
fluctutate
so that
the pattern
suggests bipolar disorder Slide39
Diagnostic Issues between General Population and Persons with ID
Challenging behaviors may be consistently under or over-
reported
Relief
staff during
weekends
Prolonged
substitute
coverage
H
igh
staff
turnover
Staff perceived medication change Slide40
Diagnostic Issues between General Population and Persons with ID
C
hallenging
behaviors are accurately reported, but variations are due to indirect effects
of:
On-site visits/inspections
Sporadic
family or close friend
contact
S
erious illness:
housemate, family or close
friend Slide41
2nd Mania
Not
ALL bipolar
-like symptoms
MEAN Bipolar
D
x
A
utoimmune
Endocrine
N
eurologic
C
erebrovascular
Metabolic
S
ubstance
withdrawal Slide42
2nd Mania
The
authors of DSM-5 opted not to include a concrete
list of medical causes
because such a list is never
complete
Clinical
judgment is critical to diagnosing bipolar disorder due to a medical
conditionSlide43
2nd Mania
Any
medical condition that can result in bipolar symptoms in the general population can cause manic symptoms in persons with
ID Slide44
Method
NADD
expert work group examined changes in the Diagnostic Statistical Manual 5 (DSM 5
)
Reviewed
pertinent evidenced-based literature for persons with
IDD
Submitted draft for
peer review
Revised draftSlide45
Method – Levels of Evidence
Type I: good systematic review and meta-analyses with at least one randomized control trial (RCT)
Type II: a RCT
Type III: well-designed interventional study without randomization
Type IV:
well-designed
observational
Type V: expert opinion, influential reports and studiesSlide46
Results
No type I or type II levels of evidence were found
Vast majority of studies were type IV or VSlide47
Results – DSM5 Modifications for Bipolar Disorder
Criterion A is revised to include increased
energy or activity
as a core
symptomSlide48
Results – DSM5 Modifications for Bipolar Disorder
A person, who
meets both the
full criteria for mania and depression, is
diagnosed
with
bipolar disorder
I
The
new
is
“with mixed features” instead of bipolar disorder I, mixed episode as in DSM-
IV Slide49
Results – DSM5 Modifications for Bipolar Disorder
The third pertinent change is the introduction of the diagnostic category of disruptive mood
dysregulation
disorder within the depressive disorders chapterSlide50
Disruptive mood dysregulation disorder
- new DSM5 category
Chronic irritability - no distinct periods of mania
Onset before 10
years. Temper outbursts inconsistent with developmental level
Present for at least 12 months; without a three-
month symptom-free period
Little is known about treatment or outcome
Often previously diagnosed with pediatric
mania
(early onset bipolar disorder)Slide51
Results
In general population, 40-fold increase in diagnosis of bipolar disorders in young people over a decade (
Blader
& Carlson,
Biol
Psychiatry 62:107-14
2007)
Level V evidence
of over-diagnosis of bipolar disorders in persons with
IDD Slide52
For a reliable bipolar diagnosis in a youth with
ID
Clear change from previous functioning
N
ot
merely a worsening of, or fluctuation
in,
a condition present since early
childhood Slide53
Over-diagnosis of Bipolar Disorder
Individuals at risk for
over-diagnosis
of bipolar disorder include those with persistent irritability Slide54
Over-diagnosis of Bipolar Disorder
Over-diagnosis
of bipolar disorder can result in unnecessary exposure and the subsequent potential adverse effects
of
psychotropic medications Slide55
IASSIDD Meeting
Colleagues from Europe and Australian/New Zealand did
not
agree that bipolar disorder was too frequently diagnosed
Is over-diagnosis of Bipolar Disorder more
typical of United States? North America?Slide56
DSM5 Bipolar Disorders
Systematic, prospective, well-controlled studies have
not
been conducted
Using
reliable means of assessing the presence of full DSM5 criteria
I
n
representative samples of people with ID Slide57
DSM5 Bipolar Disorders
Bipolar Related Disorders have RARELY been studied
Cyclothymia
Bipolar IISlide58
Caution
C
ase reports of bipolar
Chromosome
22.q11.2 deletion (
velocardiofacial
or
diGeorge
syndrome)
Chromsome
22q13.3 deletion (Phelan-
McDermid
syndrome
)
P
remature
to associate any chromosomal syndromes
with
an increased risk for
bipolar
disorder Slide59
Limitation
Data were not kept as to number of studies reviewed and those that were excluded from review involving persons with IDDSlide60
Conclusion
M
ood
dysregulation
disorder
may provide
greater diagnostic clarity for
pediatric
bipolar
disorder
The
review highlights the potential over-diagnosis of bipolar and related for persons with
IDD